Andrea Calcagno
Overview
Explore the profile of Andrea Calcagno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
227
Citations
1593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trunfio M, Scutari R, Fox V, Vuaran E, Dastgheyb R, Fini V, et al.
bioRxiv
. 2025 Mar;
PMID: 40060671
Author Summary: HIV can affect brain health and mental well-being, even in people on successful antiretroviral therapy. The reasons behind this are still unclear. HIV also influences the communities of...
2.
Imperiale D, Atzori C, Angeloro D, Murgioni A, Bagatin A, Secci V, et al.
J Alzheimers Dis
. 2024 Dec;
103(1):305-315.
PMID: 39623969
Background: Alzheimer's disease (AD) is the most common neurodegenerative dementia, with diagnosis traditionally reliant on clinical criteria. Cerebrospinal fluid (CSF) biomarkers like pTau181 and Aβ/Aβ ratio significantly improve diagnostic accuracy...
3.
Calcagno A, Pizzi C, Pocongo B, Ronzoni N, Alladio F, Francisco N, et al.
AIDS Patient Care STDS
. 2024 Oct;
38(10):463-465.
PMID: 39364627
No abstract available.
4.
Kincer L, Dravid A, Trunfio M, Calcagno A, Zhou S, Vercesi R, et al.
J Clin Invest
. 2024 Oct;
134(19).
PMID: 39352388
During antiretroviral therapy (ART), most people living with HIV-1 have undetectable HIV-1 RNA in their plasma. However, they occasionally present with new or progressive neurologic deficits and detectable HIV-1 RNA...
5.
Stroffolini G, Atzori C, Imperiale D, Trunfio M, Di Perri G, Calcagno A
Microorganisms
. 2024 Sep;
12(9).
PMID: 39338433
People living with HIV (PLWH) may present atypical neurological complications. Recently, autoimmune manifestations of the central nervous system (CNS) have been described. We retrospectively described the features of PLWH presenting...
6.
Stroffolini G, Lupia T, Gaviraghi A, Venuti F, Cinnirella G, Gori A, et al.
Infection
. 2024 Sep;
53(1):383-392.
PMID: 39302627
Purpose: Non-tuberculous mycobacteria (NTM) account for high clinical burden, and treatment can be challenging. Moreover, accessibility of NTM medications varies across centers. These challenges may lead to unplanned therapeutic changes,...
7.
Lazzaro A, Vai D, Barco A, Stroffolini G, Pirriatore V, Guastamacchia G, et al.
J Acquir Immune Defic Syndr
. 2024 Sep;
97(2):180-191.
PMID: 39250652
Background: The pathogenesis of HIV-associated neurocognitive (NC) impairment is multifactorial, and antiretroviral (ARV) neurotoxicity may contribute. However, interventional pharmacological studies are limited. Methods: Single-blind, randomized (1:1), controlled trial to assess...
8.
Calcagno A, Cusato J, Cinque P, Marchetti G, Bernasconi D, Trunfio M, et al.
Brain
. 2024 Aug;
147(11):3742-3750.
PMID: 39171829
It is debated whether CNS involvement begins during acute human immunodeficiency virus (HIV) infection in persons without meningitis/encephalitis and whether specific antiretroviral drugs or combinations would be beneficial. Neurologically asymptomatic...
9.
Longo B, Trunfio M, Calcagno A
J Antimicrob Chemother
. 2024 Aug;
79(11):2731-2741.
PMID: 39150384
Mycobacterium abscessus complex is a group of rapidly growing non-tuberculous mycobacteria (NTM), increasingly emerging as opportunistic pathogens. Current treatment options for these microorganisms are limited and associated with a high...
10.
Trunfio M, Vuaran E, Vai D, Quarta C, Di Stefano A, Imperiale D, et al.
AIDS Behav
. 2024 Jul;
28(11):3643-3654.
PMID: 39080201
We assessed whether symptomatic neurocognitive impairment (NCI) and asymptomatic NCI -of which the clinical relevance is debated- affect HIV control and the role of ART adherence in this relationship. Observational...